Nebulisation

Nebulisation is a treatment method that converts liquid medication into a fine mist which the patient inhales through a mask or mouthpiece, delivering the drug directly to the airways and lungs. It is commonly used to administer bronchodilators and steroids to relieve wheezing, breathlessness and airway inflammation in conditions like asthma and COPD. Compared to inhalers, nebulisation delivers medication more easily to patients who struggle with inhaler technique, including young children and the elderly. It is used both for acute flare-ups and as part of ongoing management in select patients.

Nebulisation is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Pulmonology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 10-15 minutes per session. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Most patients feel symptom relief within minutes of completing the session, with no specific recovery time needed. Mild jitteriness from bronchodilator medication typically resolves within an hour. Repeat sessions may be scheduled every few hours during an acute flare-up until symptoms stabilise.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Nebulisation has a documented success rate of Highly effective for symptom relief at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.